SCHEMBL6783496

SCHEMBL6783496

Cc1cc(C[CH]N)c2ccccc2n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 4/20 0.56
CYP1A2 P05177 2/20 0.55
CYP2C19 P33261 2/20 0.44
KDM4E B2RXH2 4/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
HTT P42858 2/20 0.44
RAB9A P51151 2/20 0.44
BACE1 P56817 1/20 0.43
ALDH1A1 P00352 4/20 0.43
HPGD P15428 2/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
GAA P10253 1/20 0.43
CYP2D6 P10635 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
USP2 O75604 1/20 0.42
MAPT P10636 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
GALR3 O60755 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6788357 0.83 CYP1A2 (0.55) NCF1CYP1A2CYP2C19KDM4ESMN1; SMN2
SCHEMBL5898542 0.80 CYP1A2 (0.60) NCF1CYP1A2CYP2C19KDM4ESMN1; SMN2
SCHEMBL265139 0.80 NCF1 (0.61) NCF1CYP1A2CYP2C19KDM4ESMN1; SMN2
SCHEMBL6788445 0.80 CYP1A2 (0.51) NCF1CYP1A2CYP2C19KDM4ESMN1; SMN2
SCHEMBL6790018 0.80 CYP1A2 (0.51) NCF1CYP1A2CYP2C19KDM4ESMN1; SMN2
SCHEMBL6789730 0.80 CYP1A2 (0.56) NCF1CYP1A2CYP2C19KDM4ESMN1; SMN2
SCHEMBL1366357 0.78 CYP1A2 (0.62) NCF1CYP1A2CYP2C19KDM4ESMN1; SMN2
SCHEMBL8232676 0.78 CYP1A2 (0.62) NCF1CYP1A2CYP2C19KDM4ESMN1; SMN2
SCHEMBL6783499 0.77 NCF1 (0.58) NCF1CYP1A2CYP2C19KDM4ESMN1; SMN2
SCHEMBL6494921 0.77 CYP1A2 (0.60) NCF1CYP1A2CYP2C19KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6825215-B2 N-HYDROXY-2-(2-(((4-((2-METHYL-4-QUINOLINYL)METHOXY)PHENYL) -SULFONYL)METHYL)-2-PYRROLIDINYL)ACETAMIDE, FOR EXAMPLE AND OTHER QUINOLINE CONTAINING N-HYDROXYACETAMIDE DERIVATIVES BRISTOL-MYERS SQUIBB PHARMA COMPANY 2004-11-30 US disclosed
EP-1355901-A2 1,1-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLOPROTEASE AND TNF-$g(a) Bristol-Myers Squibb Pharma Company (US) 2003-10-29 EP disclosed
WO-2002055516-A2 1,1-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLOPROTEASE AND TNF-$g(a) BRISTOL MYERS SQUIBB CO (US) 2002-07-18 WO disclosed